XML 147 R130.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 22 - Parent Corporation Only Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment consolidated net income $ 20,371 $ 17,161 $ 19,056 $ 17,205 $ 19,273 $ 21,407 $ 21,394 $ 24,929 $ 73,793 $ 87,003 $ 125,211
(Gain) loss on equity securities, net                 (2) 117 1,521
Amortization of subordinated debt issuance costs                 505 1,184 304
(Increase) decrease in other assets                 8,691 (7,514) (12,413)
Decrease in other liabilities                 (40,118) (9,248) 48,322
Net cash provided by (used in) operating activities                 60,700 92,891 176,777
Net cash used in investing activities                 55,151 (248,038) (1,543,232)
Cash dividends paid on preferred stock                 (6,036) (6,036) (6,037)
Cash dividends paid on common stock                 (27,281) (25,912) (23,428)
Proceeds from exercise of stock options                 0 96 124
Net cash used in financing activities                 (2,077) 129,546 1,369,234
Increase (decrease) increase in cash and cash equivalents                 113,774 (25,601) 2,779
Cash and cash equivalents at beginning of period       242,714       268,315 242,714 268,315 265,536
Cash and cash equivalents at end of period 356,488       242,714       356,488 242,714 268,315
Parent Company [Member]                      
Segment consolidated net income                 73,793 87,003 125,211
Equity in undistributed earnings of subsidiary                 (33,072) (41,691) (96,026)
(Gain) loss on equity securities, net                 (164) 131 45
Amortization of subordinated debt issuance costs                 505 1,184 304
(Increase) decrease in other assets                 (3) 699 0
Decrease in other liabilities                 (122) (1,384) (14)
Net cash provided by (used in) operating activities                 40,937 45,942 29,520
Payments for investments and advances in subsidiaries                 0 (32,250) 0
Repayment of investments and advances in subsidiaries                 0 32,250 0
Purchases of equity securities                 (1,533) (2,870) (3,538)
Net cash used in investing activities                 (1,533) (2,870) (3,538)
Repayment of subordinated debt                 0 (75,000) 0
Cash dividends paid on preferred stock                 (6,036) (6,036) (6,037)
Cash dividends paid on common stock                 (27,281) (25,912) (23,428)
Purchase of treasury stock                 (5,820) (17,497) (13,127)
Proceeds from exercise of stock options                 0 96 124
Net cash used in financing activities                 (39,137) (124,349) (42,468)
Increase (decrease) increase in cash and cash equivalents                 267 (81,277) (16,486)
Cash and cash equivalents at beginning of period       $ 35,885       $ 117,162 35,885 117,162 133,648
Cash and cash equivalents at end of period $ 36,152       $ 35,885       $ 36,152 $ 35,885 $ 117,162